POST-TRAUMATIC STRESS DISORDER CLINICAL RESEARCH STUDY
A Phase 3, Multicenter, Randomized, Double-blind Trial of Brexpiprazole as Combination Therapy with Sertraline in the Treatment of Adults with Post-traumatic Stress Disorder
Qualified Participants Must:
• Be 18 to 65
• PTSD Symptoms at least 6 months
• Traumatic event was not greater than 9 years ago or before age 16
• No traumatic events in past 3 months
• Not receiving disability payments due to PTSD
• Not in compensation litigation
Qualified Participants May Receive:
Investigational medications and compensation for time and travel
To learn more please call us at 866-DOC-LEON or 856-857-9500 (Extension 22 - Jen Mellon)
Click to email us.
Click here for Frequently Asked Questions about participating in our research studies.